ORLANDO, Fla.—Fasted diabetic surgical patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) present with significantly greater residual gastric volumes and risk for a full stomach, a new study has found. The investigation also showed that GLP-1 RA use within seven days of surgery was associated with significantly increased gastric volumes relative to holding therapy for more than seven days—a finding that the researchers said supports current consensus-based
AUGUST 11, 2025